Placebo for pregabalin

DRUG2 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Bayer

Conditions

Neuropathic Pain Associated With Diabetic Peripheral NeuropathySpinal Cord Injuries

Phase 2

A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain

TerminatedNCT04641273

BayerNeuropathic Pain Associated With Diabetic Peripheral Neuropathy

Start: 2021-01-22End: 2021-10-18Updated: 2022-12-12

Unknown Phase

Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

TerminatedNCT00978341

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Spinal Cord Injuries

Start: 2007-02-28End: 2008-10-31Updated: 2021-01-25

Related Papers

Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study

Pain2023-10-1810 citations